AB&B BIO-TECH-B (02627) announced that on October 15, 2025, the company submitted an application to the China Securities Regulatory Commission to convert 81.662 million unlisted shares into H shares and to list these shares on the Hong Kong Stock Exchange.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.